Podcast transcripts, polished for reading

The Brain Doctor That Figured Out The Cause Of Dementia - Dr. David Perlmutter | The Diary Of A CEO Transcript

Polished transcript · The Diary Of A CEO · 12 Nov 2026 · @healthynut

Steven Bartlett interviews neurologist Dr David Perlmutter on the causes and prevention of dementia and Alzheimer's disease

Steven Bartlett speaks with board-certified neurologist Dr David Perlmutter about the metabolic and lifestyle roots of Alzheimer's disease, the role of the brain's immune cells, and what individuals can do to protect their brain health.

Summary

A board-certified neurologist and author of Brain Defenders, Dr David Perlmutter argues that Alzheimer's disease is fundamentally a metabolic condition driven by lifestyle choices rather than an inevitable genetic fate. He challenges the prevailing pharmaceutical approach of targeting beta-amyloid plaques, calling the FDA-approved drugs "for the most part ineffective and significantly dangerous," and instead points to the brain's immune cells — microglia — as the central mechanism in neurodegeneration. Perlmutter draws on personal experience, having watched his father, a brilliant brain surgeon, decline and die from Alzheimer's over five years, as the driving force behind his mission to spread a message of prevention. He presents a wide range of evidence-backed interventions — from exercise and diet to sleep, social connection, and even 40 Hz light stimulation — that can shift microglia from a destructive to a supportive state. A Cochrane analysis of 20,342 individuals across 17 studies is cited as confirming that amyloid-targeting drugs produce no meaningful benefit, while a Harvard lifestyle intervention study showed 70% of Alzheimer's patients either stabilised or improved through diet, exercise, stress reduction, and meditation.

Key Takeaways

  • Alzheimer's is primarily a metabolic disease, not a plaque disease. Perlmutter argues that the decades-long focus on beta-amyloid plaques has been a costly misdirection — you can have a brain full of plaques and no dementia — and that the real upstream cause is disruption of mitochondrial energy production in the brain's immune cells.
  • Microglia are the central mechanism. These brain immune cells exist in a supportive state (M2) or a destructive state (M1). When shifted to M1 by poor metabolism, inflammation, high blood sugar, poor sleep, alcohol, or social isolation, they destroy synapses — the connections between neurons — producing the cognitive decline characteristic of Alzheimer's. Crucially, this shift is reversible.
  • Exercise is the single most powerful intervention. A study from the Framingham Heart Study found that the most active middle-aged people had a 45% reduced risk of Alzheimer's compared to the least active. For APOE4 carriers — who face up to a 1,200% increased genetic risk — the most active group had a 67% reduced risk. Exercise activates muscles to produce myokines that stimulate brain cell growth, improve insulin function, reduce inflammation, and increase blood flow to the brain.
  • Genetic predisposition is not genetic destiny. Carrying one or two copies of the APOE4 allele raises Alzheimer's risk significantly, but Perlmutter stresses this is a predisposition, not a determinant. Lifestyle choices can substantially offset genetic risk, making genetic testing a tool for motivation rather than a death sentence.
  • FDA-approved Alzheimer's drugs are ineffective and dangerous. A Cochrane analysis of over 20,000 patients across 17 studies found that amyloid-targeting drugs produce no meaningful slowing of progression. Perlmutter states plainly that he does not recommend their use, and that the medical establishment is beginning to shift — evidenced by a new UK trial using metformin, a diabetes drug, rather than an amyloid drug.
  • 40 Hz light and sound stimulation can revert destructive microglia. Research by Dr. Li-Huei Tsai at MIT has shown that flickering light at 40 Hz restores gamma oscillation in the brain and shifts M1 microglia back to their supportive M2 state. Interventional trials in existing Alzheimer's patients have produced results that outperform any amyloid-targeting drug.
  • The ketogenic diet directly addresses the brain's energy crisis. In mild cognitive impairment and early Alzheimer's, a ketogenic diet or ketone supplementation can rescue 10–18% of the brain's total energy supply, closing up to 80% of the fuel gap caused by impaired glucose metabolism, and producing up to 15% improvement in memory test scores.
  • Sugar exposure in utero has lifelong consequences. A study following women who were pregnant in 1953 — during wartime sugar rationing in the UK — found that children born to mothers without access to sugar had a 40% reduced risk of developing Alzheimer's decades later, suggesting that metabolic programming begins before birth.
  • Women face twice the Alzheimer's risk as men, partly explained by the drop in estradiol at menopause, which causes synapses to be tagged with "eat me" signals that direct destructive microglia to destroy them — a mechanism demonstrated by Dr. Beth Stevens at Harvard.
  • Social connection and restorative sleep are underrated brain protectors. Both work through the same microglia pathway: oxytocin released during social bonding keeps microglia in their supportive state, while even a single night of poor sleep dramatically reduces the brain's ability to clear beta-amyloid and impairs the prefrontal cortex's ability to regulate impulsive decision-making.

  • FULL TRANSCRIPT

    Introduction and Dr. Perlmutter's Mission

    Steven Bartlett: Dr Dr David Perlmutter, what is the mission you are on and why does that mission personally matter to you?

    Dr Dr David Perlmutter: The mission I'm on is to let as many people know that the destiny of their brains is really based upon how they are choosing to live their lives today. We live in a world where we're sort of messaged to live your life however you like, come what may, and there'll be some magic development in the world of neuroscience that will save you when your brain isn't working like it should. We aren't there yet. I welcome that day, but we aren't there yet. What we really understand now — in fact, the greatest development in neuroscience — is that our lifestyle choices are really the architects of our brain's destiny.

    Steven Bartlett: And who are you, Dr. David? What is your experience and what is the education that you've had?

    Dr Dr David Perlmutter: I went to medical school, got my MD, then enrolled in a neurosurgery residency and became a board-certified neurologist.

    Steven Bartlett: And why does this all matter so much to you personally?

    Dr Dr David Perlmutter: Personally, I've been through this with my father. And it's rough. It's rough for the 7.6 million Alzheimer's patients in my country — not so rough for them as it is for their families, the truth be known. And it is significantly preventable. That's the message that I've got to get out. We don't have a treatment. Would I welcome a treatment? You bet. Would I have used a medication and prescribed it for my own father? Of course I would have. We aren't there yet.

    Steven Bartlett: What happened to your father? I've got a wonderful portrait of him here as well. What a suave man.

    Dr Dr David Perlmutter: He was a brilliant brain surgeon — compassionate, skilled, wonderfully compassionate individual. And in his later years, he developed Alzheimer's. It's interesting because I diagnosed him late in the game. I remember the moment that I finally realised, my gosh, he's demented — and I missed it.

    Steven Bartlett: How did you know he had Alzheimer's? How do you diagnose it?

    Dr Dr David Perlmutter: It's what I do. I diagnose Parkinson's in the airport when I'm coming to see you. That's my skill set. Just the type of memory issues that he was experiencing — losing things, walking into a room and forgetting why he was there — it was very obvious. It was at least dementia, and generally that means Alzheimer's.

    Steven Bartlett: Just for my knowledge, what is the difference? I hear these words — dementia, Alzheimer's, Parkinson's.

    Dr Dr David Perlmutter: Most of dementia is Alzheimer's. You can be cognitively impaired because of poor blood supply to your brain — we call that vascular dementia. There is dementia that goes along with the accumulation of something called Lewy bodies in the brain. People can be cognitively impaired with reversible issues, such as a consequence of medications they may be taking or other types of medical problems. So dementia is the umbrella term. It means failure of cognitive function across multiple domains.

    Steven Bartlett: Okay. So Alzheimer's disease, vascular dementia, Lewy body dementia, and —

    Dr Dr David Perlmutter: Frontotemporal dementia.

    Steven Bartlett: Okay. So everything underneath dementia — it's a general term for a group of symptoms.

    Dr Dr David Perlmutter: That's right. What has become so fascinating is that as you look at those seemingly very disparate diagnoses — and they are — they're all united by one common mechanism, and that is disruption of the brain's immune system. That is the fundamental. That is the huge aha in neuroscience right now: that disruption of the brain's immune system is a central feature across this incredible panorama of what makes a good brain go bad.

    Challenging the Beta-Amyloid Theory

    Steven Bartlett: What is it that the current medical profession believes that you no longer believe?

    Dr Dr David Perlmutter: I think that by and large, at least relating to Alzheimer's, the party line is still one that believes the central player in Alzheimer's disease is the accumulation of a protein called beta-amyloid in the brain. Get rid of the beta-amyloid and problem solved. That is not reality, and it's unfair.

    Steven Bartlett: And how many people are likely to get a form of dementia in their life? How many people are going to be affected by these neurodegenerative diseases?

    Dr Dr David Perlmutter: Lots. If you live to be age 85, your risk of developing dementia — and generally Alzheimer's — is close to a flip of a coin. It's close to the high 40s percent. And that is very worrisome. In America, Alzheimer's is the third leading cause of death. People don't realise that. And it is largely preventable. That gets back to our first question. Why am I here? What do I do? My mission is to message people that what you're doing at your age, Steven, is hugely influential in terms of charting your brain's destiny.

    Steven Bartlett: When does dementia start?

    Dr Dr David Perlmutter: Typically we discuss the idea that somebody is having issues — forgetting names, walking into a room and forgetting why, losing things — that's when they go to the doctor and the process begins of evaluation and ultimately choosing some form of treatment. The reality is it's like a heart attack. We don't wait for you to have a heart attack to begin looking at your blood lipids, your blood pressure, asking you if you're active, how you're sleeping. We should be doing the same thing as it relates to dementia. We should be talking to people in their 30s and 40s and asking those very same questions.

    Alzheimer's is primarily a metabolic condition of the brain. Let me tell you something really interesting that happened in your country this past week. There is a new trial being started right here in England called the ADS Smart Trial, and the government has put up £33 million — $44 million — to begin a study of two medicines in the treatment of Alzheimer's disease. One is called metformin, which is a diabetes pill, and the other is actually an ADHD drug called Strattera. This is a trial of about a thousand people and it's going to take 18 months. Your prime minister is very much in favour of it — his father died of dementia. The reason I bring it up is that metformin is a metabolic drug. It's a diabetes drug. Think about that — they've moved away from targeting beta-amyloid to finally recognising that metabolism is a central player here.

    Steven Bartlett: Explain this to me like I'm 16 years old. So beta-amyloid are these brown plaques they found on the brain with people that had Alzheimer's dementia. They thought it was part of the cause of the dementia. Subsequently they found out that you can have those plaques and still not have the dementia symptoms. So we now know it must be something else — you can have a brain load of plaques and not be demented. So now the working hypothesis is that something else is causing it. And you're positing that it's largely based on metabolism.

    Dr Dr David Perlmutter: Yes. And metabolism — the strict definition is the way that our cells create energy and make things. They make proteins, they make things. So really, upstream of what makes a good brain go bad are changes in metabolism. The metabolic markers — our blood sugar, our blood pressure, our body fat, our blood lipids — these are the metrics of metabolism that are so important for the brain and the heart and in fact your entire body.

    So when we say that Alzheimer's is fundamentally a metabolic condition, let's say that in the context of where the research is going. For example, 10 years ago about a third of Alzheimer's research was really focused on this beta-amyloid protein. That number is down to about 14% now, in favour of looking at things like metabolism and looking at the brain's immune system — these microglia cells that are really the upstream issue as it relates to not just Alzheimer's but all manner of neurodegenerative condition.

    So when we understand metabolism and its effect on the microglia cells, we're throwing a very wide net indeed. If we can target our metabolism earlier in life — keep our blood sugar under control, exercise, get enough sleep, have relationships with other people — who knew that was such a powerful tool for brain health — we really are creating an environment that helps us reduce the risk across the spectrum of brain degenerative issues, not just Alzheimer's.

    The Top Five Lifestyle Contributors to Alzheimer's

    Steven Bartlett: I've got some cards here and I want you to write in order of severity and consequence the top five things that you think from a lifestyle perspective are contributing to Alzheimer's and dementia. How many have you got?

    Dr Dr David Perlmutter: I have five. And again, let's restate what I'm doing here. I'm putting forth what I think are the most important things people can be doing as it relates to being in charge of their brain. And that is in fact number one — and that is the biggest issue — not embracing the fact that you are the architect of your brain's destiny. Because if we don't do this, nothing here will matter. You've got to embrace that and recognise that we have offloaded agency of our brains to the pharmaceutical industry, if you will, and other forms of technology. And again, that's great if there were something effective. There is not anything meaningfully effective right now. John Kennedy said that the time to fix the roof is when the sun is shining. And that's why I'm here today.

    Number two: sedentarity — meaning being sedentary. This is huge. Exercise and movement is a multi-tool for the brain. It targets the function of insulin. It targets inflammation. It targets mitochondrial function. It targets blood flow. These are all hugely important mechanisms in keeping the brain healthy.

    Steven Bartlett: Are you somewhat very focused on brain health in part because of your father, and does that statistically give you a predisposition to the same disease?

    Dr Dr David Perlmutter: It does. When we talk about what we inherit in terms of risk, I think a lot of people these days are focused on the Chris Hemsworth story — that he carries two of what are called the APOE4 genetic alleles. We have the APOE alleles. We can have a 2, a 3, or a 4, and you carry two of them. So you can have a 2/2, a 2/3, a 3/3, a 3/4, a 4/4, and a 2/4. Carrying more of the APOE2s is associated with a pretty dramatic risk reduction. APOE3 is neutral. But carrying the APOE4 allele — about 25% of people — is associated with an increased risk of Alzheimer's. If you carry one, by about fivefold — 500%.

    Steven Bartlett: 500%, fivefold. And if you carry two?

    Dr Dr David Perlmutter: If you carry two — in other words, you're APOE 4/4 — the risk may be as high as a 12-fold increase.

    Steven Bartlett: 1,200%. And you're saying Chris Hemsworth has —

    Dr Dr David Perlmutter: He's been very public about it. But here's what is so valuable. People are getting their genome sequenced now left, right, and centre. A quarter of people who get their genome sequenced are getting their results back and seeing that they might carry an APOE4 allele. And then you read the little printout from AI that says this puts you at increased risk for Alzheimer's. That's scary. That's worrisome.

    Early on, we as neurologists were told that when we know the APOE status of our patients, if they carry APOE4, we shouldn't tell them. Why? Because they're on the road to Alzheimer's. Nothing is further from the truth. If you carry an APOE4 allele or two, you are not necessarily destined to get Alzheimer's. Your lifestyle choices can offset this issue of a genetic predisposition. It's a genetic predisposition — I won't deny that. It is not a genetic determinant.

    There's an interesting study that came out in the Journal of the American Medical Association in November of 2025. The author was named Marino, and what he did was look at people from the Framingham Heart Study. He divided the group of individuals — about a thousand in each group, 4,000 total — into younger people aged 25 to 44, middle-aged people 45 to 64, and older people 65 to 88. He followed these individuals for a number of years and determined who got dementia and who did not, and compared that to their level of physical activity.

    What he found was really quite remarkable. In middle-aged people, those who were the most active compared to those who were the least active had about a 45% risk reduction for Alzheimer's — for which there is no meaningful treatment. That's huge. Similar results in the older age group. Those who were most active and carried APOE4 had about a 67% reduced risk of becoming an Alzheimer's patient if they were in the group that exercised the most in comparison to the group that exercised the least. Exercise is the multi-tool here. It is a huge and readily available tool for each and every one of us. That's what doctors should be teaching patients — not, "Well, it looks like you're cognitively impaired. We're going to put you on an IV therapy every two weeks and hope for the best."

    Steven Bartlett: What is the exercise doing physiologically? How is it helping the brain?

    Dr Dr David Perlmutter: It's doing a lot of things. Exercise means you're basically activating muscle — that's how you move. And as it turns out, your muscles are an endocrine gland.

    Steven Bartlett: What does that mean?

    Dr Dr David Perlmutter: Our endocrine glands are the adrenals, the thyroid, the pituitary. They're called endocrine glands because they make chemicals that go elsewhere and do something. Your muscles create a suite of chemicals called myokines. Myo means muscle, kines means they move around and do things at a distance. They make their way to the brain. For example, they help stimulate the brain to produce something called BDNF, which grows new brain cells and nurtures your neurons and the connections between neurons — the synapses.

    When we activate our muscles, we improve how insulin works so our blood sugar can remain where it needs to be. Elevated blood sugar is a powerful risk for brain degeneration. A simple blood test like the A1C, measuring your average blood sugar, is a powerful indicator — if it's elevated — of risk for Alzheimer's. When we exercise, we reduce inflammation. Inflammation is a key mechanism that changes our brain's immune cells from being supportive to being destructive. And exercise improves the blood going to your brain. That's got to be a good thing.

    Steven Bartlett: Any particular type of exercise, or all exercises?

    Dr Dr David Perlmutter: I think all exercise is great. The big discussion is, what's best for my brain — aerobics or strength training, resistance training? A recent meta-analysis asked that question and came to the conclusion that it's both. We want to strengthen our muscles and we want to engage in aerobic activity to gain the metabolic benefits. But think about it — if these chemicals that your muscles are making are good for your brain, the more you have of these chemicals, the better. So build muscle. When you're my age, it's harder — it's much more challenging to keep your muscle mass and to build muscle. So it's something you really want to start at a younger age.

    Steven Bartlett: What's the next card? I think we've got a toolbox here as well which has got some things in it.

    Dr Dr David Perlmutter: The goodie box. I'm going to pull out a very, very high-tech device that I think people should get. It might be their most powerful tool that they can save up for so that they can improve their brains. Ready? Here's one. And here is the other. Get moving. Movement moves all the needles. Movement moves everything.

    Steven Bartlett: This is better than any drugs or medicine that I could possibly buy.

    Dr Dr David Perlmutter: It is. What I've just described to you in terms of the activity of muscle activation is very similar to the drug that's now being used in the Alzheimer's trial right here in England. Metformin does many things that exercise does. Exercise does more.

    Steven Bartlett: Sold.

    Dr Dr David Perlmutter: Mission accomplished. Lack of social connection. Who knew?

    Steven Bartlett: Really? That's the third thing?

    Dr Dr David Perlmutter: From here on out, these are all equally ranked.

    Steven Bartlett: Okay, so this is in the top five. Lack of social connection. What evidence is there that relationships and social connection correlate to dementia?

    Dr Dr David Perlmutter: It's a tough metric, isn't it? How does one measure that? We first got an inkling that social connectivity was good for health, good for the body, and good for the brain from the Blue Zones information that looked at people who lived long and had lower risk of dementia. These are individuals who ate a certain diet and lived in areas that had a lot of verticality — meaning they were going up and down steps. But importantly, what we learned from the Blue Zone data is that these are people who are connected to other people. They've insinuated themselves into community, and that is good for the brain. It's good for inflammation. It's good for metabolism.

    You would ask, as I have asked, what is the mechanism? What we know is that when we connect to people and develop a relationship, our brains increase their output of a chemical called oxytocin — the love hormone. But it's more than that. This oxytocin is secreted when we're feeling trust for another individual, when we're feeling connected to another. I'm getting oxytocin from my time spent with you today. And this oxytocin stimulates our good brain immune cells — these microglia cells — and helps keep them in their supportive, loving, nurturing role as opposed to letting them drift to becoming what I call the evil twin, increasing inflammation and increasing the destruction of our synapses.

    The Microglia: The Brain's Immune System

    Dr Dr David Perlmutter: Let me set that up a little more because I think we're going to rely on it moving forward. Our brain's microglia cells can exist in a supportive, loving configuration — we call this the M2 configuration. They have long arms that are able to reach out and be effective and do good things.

    Steven Bartlett: What is a microglia cell?

    Dr Dr David Perlmutter: A microglia cell is an immune cell that lives within your brain. It makes up about 10% of your brain cells. People say, "Well, brain cells — those are neurons." But there are other cells in your brain aside from the neurons. There are immune cells. There are cells involved in the structure of the brain.

    These wonderful, loving, nurturing microglia cells — M2 — are going around shoring up our synapses, the connection of one neuron to the next. They are making sure that our very valuable blood-brain barrier is working and keeping the bad things out. They are making sure that our neurons are functioning appropriately and are healthy. They're basically doing good things. But they can shift. They can become what I call the evil twin — the M1 microglia cell. The reason I call it an evil twin is because they're genetically the same, like twins. But this is the cell that is destructive. These are the cells that destroy our synapses. And when our synapses are destroyed, we lose connection — at a microscopic level because our synaptic connections are lost, and at a macroscopic level whereby we no longer are able to connect to other people, to ourselves, to the world around us.

    This shift from M2 to M1 is the fundamental upstream event in Alzheimer's disease. These cells are sensitive to our metabolism. When our blood sugar is elevated, it shifts them to being destructive. When there's inflammation in the body making its way to the brain from any source, it shifts the M2 supportive microglia to being destructive.

    Most importantly, the energetics of these cells is playing a fundamental role. The M2 cell gets its energy from active function of the mitochondria — it contains a host of mitochondria producing the currency of energy called ATP. The M1 cell uses a totally different energy production facility called glycolysis. So upstream of this shift are changes in the mitochondria. This is what's upstream. This is the fundamental. Mitochondrial energy production is what dictates the shift between M2 and M1.

    I fully recognise that there are countless transitional states between M2 and M1. It isn't a binary issue — it's an analog issue going from M2 supportive to M1. But again, upstream of all of this is the energetics. It's the mitochondrial function. And this is what is so sensitive to our metabolism, to insulin, to exercise on the positive side, to metformin on the medication side.

    Steven Bartlett: We're damaging our mitochondria and that's causing it to malfunction and then change from M2 to the evil twin.

    Dr Dr David Perlmutter: That's exactly right. These M2 microglia cells and M1 cells have receptors that are receiving information — inflammatory chemicals from anywhere in the body. A leaky gut, for example, creates increased inflammation in the body. Those chemicals can make their way to the brain, and there are receptors on the microglia cell that will shift it to becoming more destructive.

    Steven Bartlett: So the effect is the shift from M2 to M1 — from the normal twin to the evil twin — because something goes wrong with my energy production system, i.e. my metabolism.

    Dr Dr David Perlmutter: Yes. But there are two inputs here, and it goes both ways. When these microglia shift to being more destructive, they downregulate or reduce the function of their mitochondria.

    Steven Bartlett: Okay, so it goes back upstream.

    Dr Dr David Perlmutter: It goes back upstream — creates a feed-forward process. And importantly, these cells are pro-inflammatory, meaning that once they become activated, they're secreting chemicals of inflammation throughout their local environment in the brain. And those chemicals come back and target the healthy microglia cells and further shift them over to the dark side — like zombies.

    Steven Bartlett: How do we know that these microglia cells are anything to do with Alzheimer's and dementia?

    Dr Dr David Perlmutter: We can actually see that on a special scan called a TSPO scan. What we're looking at right now — this is the healthy control here. And when we image on this PET scan for TSPO in the Alzheimer's brain, you can see it is absolutely just lit up. And what is so incredibly empowering — what takes this story to a very wide net — is that we see positive TSPO imaging, meaning activation of the brain's immune cells, across a wide variety of neurodegenerative issues.

    Here's the empowering part: these cells can shift back and become supportive again. And the influence that directs them back to being supportive is under our control.

    Steven Bartlett: I've seen this kind of photo a few times. Is that really what an Alzheimer's brain looks like?

    Dr Dr David Perlmutter: It is. And I've seen a lot of brains.

    Steven Bartlett: How many brains do you think you've seen?

    Dr Dr David Perlmutter: Real brains — a hundred. Brains in my hands in my laboratory. And then scans — thousands of scans.

    Steven Bartlett: And have you seen an Alzheimer's brain?

    Dr Dr David Perlmutter: Countless times. I think this is an extreme example, but what we're seeing here is what we call atrophy. The valleys between the mountains are wider because the mountains have shrunken. And then the inside of the brain — these are called the ventricles, they are filled with spinal fluid — are expanding to take up the empty space. We always have to be careful — we only look at this image and don't look at the whole picture in aggregate. This could be an indication of something called hydrocephalus, where fluid is increasing in the brain and makes these ventricles larger. But it's just expanding because the brain is basically shrinking.

    Steven Bartlett: And the brain could be shrinking for any number of reasons.

    Dr Dr David Perlmutter: Yes. But keep in mind that your brain will shrink as you age — the extent that you're seeing in these images is really extensive. This is a characteristic macroscopic appearance of an Alzheimer's brain. There are microscopic characterisations as well, and blood characterisations as well.

    Synaptic Pruning and the Developmental Connection

    Steven Bartlett: My sister-in-law just had a baby. I vaguely remembered some stat that some neuroscientist on this show had told me. I Googled it and it said that we have more brain connections at two years old than we do when we're an adult. The brain basically up until two has all these incredible connections — which probably explains why kids are so good at learning stuff. And then the brain kind of loses the connections so it can reinforce the ones that matter. I was in part trying to figure out if this explains why kids have terrible twos.

    Dr Dr David Perlmutter: We are going to go to a really cool place right now. What you're describing is something called synaptic pruning, where the brain becomes much more adept at what it's ultimately going to need to do. The rate of synapse or connection formation at age one year is about one million synapses being formed every second.

    Steven Bartlett: So what does that mean?

    Dr Dr David Perlmutter: That means that in this brain, nerves are wiring up — connecting to each other — at the rate of a million connections per second in the one-year-old. Now, this idea of synaptic pruning — the refinement part — is happening at about 20% of that rate, meaning that while these connections are being made, about 20% of those connections or others are actually being destroyed. So the brain is refining itself.

    What is the mechanism whereby this synaptic pruning — this refinement — takes place? The microglia cells. The microglia cells are the ones that are appropriately destroying or taking away these synapses, which is a normal activity. It's what we want to happen. There are situations when there's not enough synaptic pruning, and there are consequences. Autism spectrum disorder is one of them. Fragile X syndrome is another. These are situations where the brain doesn't adequately synaptic prune — they're called hyperconnection syndromes, where the brain is actually overconnected.

    Think about it though. These same microglia cells that are involved in appropriate synaptic pruning when we are children are the same microglia cells that inappropriately digest away or destroy our synapses when we are older, and that can manifest as Alzheimer's disease. There's a thinking now in neuroscience that Alzheimer's is the reactivation of a normal developmental event. How cool is that? That Alzheimer's — the loss of our synapses, which is characteristic of this disease — is a reactivation of what would have been normal when we were children.

    Steven Bartlett: So the brain is pruning itself inappropriately. Why might it be doing that?

    Dr Dr David Perlmutter: That is the million-dollar question. It's doing that for a number of reasons — first because of the activation of these microglia cells, which is not appropriate. To be fair, the biggest input that relates to the shift of the microglia cell from supportive to destructive is our chronological age. I say that because that's what the data says, but I believe it should be our biological age. And the reason I say it could be our biological age is because it opens the door for us to target our biological age through exercise and diet. But that said, it is a consequence of aging and helps us understand why the number one risk factor for Alzheimer's is the number of birthdays we've had. Can't really change that, but we can change these other input sets for sure.

    Sleep, Decision-Making, and the Prefrontal Cortex

    Steven Bartlett: So what is number four?

    Dr Dr David Perlmutter: Non-restorative sleep.

    Steven Bartlett: Non-restorative sleep. How would you know?

    Dr Dr David Perlmutter: Well, you'd wear a wearable device. You could subject yourself to a formal polysomnography, which means you're going into a lab. I've done it — it's creepy. You wear all kinds of things measuring your heart rate, your brain waves, your blood oxygenation, and somebody's watching you and recording you all night long. But you have access to an Oura ring, an Apple Watch, a Whoop, and you can measure your sleep and with pretty good reliability get a sense of its quality and its quantity.

    Restorative sleep is so important. It allows us to consolidate our memories and experiences in REM sleep. It allows activation of the glymphatic system that allows us to take out the garbage — basically — which new research indicates also happens when we move. Yet another part of the motion multi-tool. Sleep helps us reduce inflammation as well. It improves insulin functionality. These are key players that relate to brain function and health preservation. Even one night's poor sleep dramatically changes the function of insulin, has a significant effect upon our blood sugar control, and really does set the stage for degeneration. Not only that, but it significantly affects our decision-making ability after just one night of poor sleep.

    Steven Bartlett: I've heard about this glymphatic thing. And ever since I heard about the glymphatic drainage system, I have slept significantly better. The way I describe it — which I'm sure is being scientifically butchered — is that at nighttime it's almost like the street cleaners come out in our brain.

    Dr Dr David Perlmutter: That is a perfect metaphor.

    Steven Bartlett: And they come out and sweep up the streets. But they're only coming out if you're in deep sleep. How long does it take to get into deep sleep?

    Dr Dr David Perlmutter: Deep sleep is something that typically happens later on in your sleep cycle.

    Steven Bartlett: For me it's around hour five and a half.

    Dr Dr David Perlmutter: Hour five and a half. So you have more deep sleep further into the night. And you sleep in these cycles — 60 to 90 minutes, depending on the person. The fact is we cycle through various aspects, and each area gets to practice a little bit, and it all converges on what we call somniferous sleep — somniferous means health-providing.

    I used to really think of sleep as non-negotiable, but now I really do prioritise it. I used to think in my earlier years that if I slept I was being unproductive, and now I've kind of inverted that — I feel like I'm being unproductive if I haven't slept.

    The other thing that fleshes this out is the idea that sleep dramatically affects your decision-making ability the next day. There are two areas of the brain that are fundamental for how we make our decisions. The prefrontal cortex — here, the frontal lobe — takes up about one-third of the entire cortex. And another area for decision-making is deep within the temporal lobes — it's shaped like an almond and it's called the amygdala. Some people call it the fear centre.

    Within the temporal lobe, inside of it, is this almond-shaped area called the amygdala. Both of these areas play important roles in decision-making. The amygdala is an impulsive, self-centred area that makes rapid decisions.

    Steven Bartlett: Well, I'm tired.

    Dr Dr David Perlmutter: We'll get there. The prefrontal cortex — again, this area behind your forehead — is the adult in the room, basically. What happens as we reach our teenage years is this prefrontal cortex takes control. The adult in the room hopefully becomes more and more influential and exerts what we call top-down control over the amygdala. So we're less impulsive. We understand the consequences of our actions. We can plan for the future. We can think about how it's going to affect not just me but you, the planet. That's the prefrontal cortex.

    We depend highly upon this top-down control of the prefrontal cortex reining in the amygdala. The problem is things can threaten that connection, and one of those things is inflammation. Inflammation can dramatically reduce the functionality — the ability of the adult in the room to be in charge. If you are chronically inflamed, your decision-making is suffering day in and day out.

    Let me take this a little further because it's an interesting concept. Food has a role in inflammation. We used to call it the standard American diet — I think kind of blaming America for the crappy diet of the world today. But it was the standard American diet, then became the western diet, and now it's pretty much the global diet that so aggressively features these ultra-processed foods that are pro-inflammatory. The world is eating foods that are increasing inflammation. And inflammation separates the connection between the adult in the room and the impulsive — we're the best, I want it for me, that's it, it's going to be my way — globally. This allows us to relate the change in global nutrition to some of the things we're seeing happening in our world today.

    Diet, Sugar, and the Continuous Glucose Monitor

    Steven Bartlett: And does this link to card number five of your top five?

    Dr Dr David Perlmutter: Poor diet. I've got a few things here in terms of food. Some orange juice. A can of beer. A big tray of food. We want to do our best to avoid sugar. Let's say this is 12 ounces. Why don't you tell me, Steven, how much sugar is in here?

    Steven Bartlett: Do you know what? I'm closer to the answer now I've done this podcast. If you'd asked me when I was younger, I would have said one.

    Dr Dr David Perlmutter: Okay, one. You tell me when to stop. That's two. Three. Can I stop?

    Steven Bartlett: I mean —

    Dr Dr David Perlmutter: Four. Five. Six. Seven. Eight. And if this were a can of soda, just two more. Eight teaspoons of sugar in your wonderful glass of oranges. But what about the vitamin C? What about the fibre? It doesn't offset what this is doing to your body.

    Steven Bartlett: Isn't it crazy that we wake up in the morning and drink eight teaspoons of sugar? And there was a narrative at one point that it was healthy for you. Back in the Sunny D days, I thought if I drank orange juice — I thought it was like one of my five a day fruit and veg.

    Dr Dr David Perlmutter: Yeah. How old are you?

    Steven Bartlett: 34.

    Dr Dr David Perlmutter: 34. You are the perfect population that needs to get this message because right now your metabolism is being formed. If we can get this message to your age group, it will have a huge outcome. When you get to be my age — and you will get to be my age — you will wish you had known this.

    Steven Bartlett: Why?

    Dr Dr David Perlmutter: Because you'll have set yourself up for a good brain. I gave a talk the other day in Vancouver, British Columbia, and I started off by asking everybody in the audience to close their eyes. I said, "I want you to imagine when you open your eyes, you're 85 years of age. Now open your eyes. Look around the room. I'm going to draw a line right down the middle of the room. Half of you have now been diagnosed with dementia. Which half of the room are you going to be in?" And what we're talking about right now allows you to be the arbiter, the architect, the decision-maker in terms of which half of that room you're going to be in.

    Now, these issues can happen in your 60s, they can happen in your 70s — which is not to say that there are not some very promising things in development right now that if we have time we can talk about. The future looks bright from that perspective. But Benjamin Franklin said that an ounce of prevention is worth a pound of cure, and it makes all the sense in the world.

    Steven Bartlett: I think this is probably one of the most important things that I did in terms of figuring out the truth about the foods that I loved. Why do you think this is so useful?

    Dr Dr David Perlmutter: For the reason that you just described. We're talking about a continuous glucose monitor. This is personalised medicine. How do your food choices affect your blood sugar, and your blood sugar affects your brain's destiny — and your heart and your body for that matter? This is how you will know. For me, it was cashews. I had no clue that cashews — nuts — would raise my blood sugar the way they did. I had a tendency to overeat cashews. I thought they were safe. I was also very surprised at the degree of my blood sugar elevation with exercise, though it was transient while I was beginning to exercise. That's a normal response and I knew it. But when I finally saw it play out on my smartphone while I was running, it was impressive.

    I'm not saying you need to wear a CGM at all times, but I think it's extremely valuable and now available without a prescription. There was a big pushback in America about making continuous glucose monitors available to people without a prescription. There were editorials written in journals saying, "Oh my gosh, people are going to be neurotic. They shouldn't know this information. This is the purview of the doctor." And my argument was, if people shouldn't have their data, then we shouldn't allow people to buy a bathroom scale. Same thing.

    These little devices don't cost a lot of money — $20, $30. You can get them on Amazon and lots of other places. You stick it to your arm, or you prick your finger, but I think the best ones are the continuous ones where you stick them on. You can record your data and upload it directly to your phone. The main thing is, how do you know what your changes are doing unless you're able to measure them? If you want to lose weight, you go on the bathroom scale frequently and see if it's working. You want to get your blood sugar under control — and you should. How would you know? To go to the doctor once a year and have a fasting blood sugar measurement — I'm not going to say it's useless, it'll give you a clue, but we can do so much better.

    Steven Bartlett: A few things that I've discovered from looking at my own continuous glucose monitor that surprised me — things that I liked but am now a little more conscious of. One of them is barbecue sauce, which I loved. It's 40 to 50% sugar, which shocked me. Balsamic glaze, 40 to 50% sugar. I had this commercial fat-free French dressing which turned out to be 35% sugar.

    Dr Dr David Perlmutter: Why fat-free?

    Steven Bartlett: It said fat-free on it. I thought it was healthy.

    Dr Dr David Perlmutter: Yeah, they do a lot of those tricks on labels. That's really worrisome that you gravitated towards something that was fat-free. Fat-free cookies, fat-free — and the other one's gluten-free. There's crap on the gluten-free aisle in the grocery store.

    Steven Bartlett: Another thing I learned from this podcast is that roughly 1% of the world are truly gluten intolerant, yet 20% of us — including me — buy gluten-free stuff. I actually used to go around saying I was gluten-free, but having learned a few things on this podcast, I think I might actually be fructan intolerant.

    Dr Dr David Perlmutter: I would say respectfully that the number of people who are gluten sensitive is probably more than that. There is a defined entity now called non-coeliac gluten sensitivity. The classic gluten issue is of course coeliac disease, which is an autoimmune condition. There are blood markers for it. There are diagnoses made by looking at the small bowel with an endoscope. And the reality is that a lot more people have non-coeliac gluten sensitivity than have full-on coeliac disease. So I think it's a big number.

    I was very taken by the work many years ago of a Dr. Marios Hadjivassiliou, who's actually here in England at Sheffield Hospital, who described issues related to the brain that weren't related to coeliac disease but were related to gluten consumption. That got me launched in a big way to looking at gluten as it relates to the neurological consequences in some people of consuming gluten.

    I remember one time as I was beginning to learn this and reading his work — he was describing how some people have headaches from consuming gluten. Who knew? And I had a patient with lifelong headaches who was on narcotics for her headaches. I said, "Hey, what the heck? Let's give it a shot. Let's go gluten-free. See what happens. Come back in six weeks." She came back in six weeks and remarkably, she was headache-free. She was off narcotics. So she went to a gastroenterologist because she had gluten issues probably related to GI symptoms as well. And she said, "I saw Dr. Perlmutter and he put me on a gluten-free diet. Now my headaches are gone." And the doctor said to her, "That's preposterous. And to prove it to you, I'm going to do an endoscopy. I'm going to look at your small intestine and prove that you don't have coeliac disease." He does an endoscopy. She doesn't have the hallmarks of coeliac disease. And he says to her, "Go back on gluten." She goes back on gluten. What happens? Headaches returned with a vengeance.

    Steven Bartlett: What I read was that roughly 0.5% of the general population have non-coeliac gluten sensitivity. In terms of coeliac disease, it affects roughly 1% of people. And then 0.1% of people have a wheat allergy. But when you survey the general population about being gluten-free, up to 20% of adults report feeling much better on a gluten-free diet. However, double-blind placebo-controlled food challenge trials show that only a fraction of self-diagnosed individuals react specifically to gluten. And generally, I think a lot of people are actually intolerant to fructans — and fructans and gluten always appear at the same time. This also explains why when you go to certain countries and have really good ingredients — I often cite Italy for the pasta — where they don't have fructans, you don't have the same response. But it could also just be the total net carbohydrates, or the calorie reduction, or placebo.

    Dr Dr David Perlmutter: I'll give you one other thing not mentioned, and that is that in America — though we don't have GMO wheat — GMO crops are created such that glyphosate, or Roundup, can be sprayed to kill the weeds while the plant is resistant and will survive. So they've not really done the GMO wheat thing yet. Therefore you would think there wouldn't be any glyphosate on the wheat. That's a wrong assumption. Glyphosate in America is sprayed on the wheat to desiccate it — to dry it out so they can get more wheat to market more quickly. And that might be another factor. Glyphosate is residual in these foods that we eat, and glyphosate has a significant effect on the gut microbiome.

    Steven Bartlett: Okay. So it could be the chemicals they're spraying on the food as well.

    Dr Dr David Perlmutter: That's right. We were told that the science was that glyphosate only affects plants, and since you're a human, you shouldn't worry about it. Well, it affects plants and it affects bacteria. But we humans — why should we care? Well, we've got billions and billions of bacteria that live within us that we depend upon to be healthy. So here we are consuming a chemical — and it's in all of us — that can affect the bacteria that live within us.

    And here's another bit of a stretch, but I think really fascinating. Mitochondria were originally bacteria. These mitochondria are very much still like bacteria — they have a circular DNA like bacteria, and they are sensitive to glyphosate. Glyphosate is a mitochondrial toxin. So that's what we are consuming when we are consuming foods that have been sprayed with this herbicide.

    Polyphenols, Chocolate, and the Mediterranean Diet

    Steven Bartlett: What about these other things? What's your take on some of these other foods here?

    Dr Dr David Perlmutter: What I'm seeing here are wonderful foods. This looks like chocolate, onions, blackberries, I think this is supposed to be Himalayan tartary buckwheat. These are foods that are rich in what are called polyphenols. That's what gives them their colours. That's why the blackberry is black. That's why the onions are coloured. We have blueberries and raspberries as well. Do they contain sugar? Yes, they do. But they contain sugar in a way that is released more slowly into the body, and coupled with the polyphenols — these are chemicals that are read by our gut bacteria. In other words, these are signalling our gut bacteria to do good things, to increase their antioxidant production, to create chemicals that are good for the entire body. So we're nurturing ourselves but we're also nurturing our gut bacteria. This Himalayan tartary buckwheat is probably one of the richest sources of these polyphenols on the planet.

    Steven Bartlett: What's a polyphenol and how does that help my brain?

    Dr Dr David Perlmutter: A polyphenol is a targeting molecule that activates pathways to create antioxidants in the body. They activate a pathway called the NRF2 pathway, and that increases our detoxification, increases our production of antioxidants, and reduces inflammation. All the good things. What I'm not seeing here is the number one source of polyphenols on the planet, at least in terms of consumption. That is coffee.

    In America, 60% of the calories that adults consume are derived from ultra-processed foods. They're processed such that these polyphenols are processed out of the foods, and what we're getting are foods that by and large have added sweetener and have all kinds of issues related to even just the processing of them.

    Extra-virgin olive oil is one of the foods with strong levels of polyphenols that I love and eat a lot of.

    It really is one of the keys we've now come to understand of the so-called Mediterranean diet. Unfortunately, if you travel the Mediterranean now, you'll see that they're eating not the Mediterranean diet anymore. And I like that you have chocolate on the plate, by the way. Chocolate's good.

    Steven Bartlett: Chocolate's good. Polyphenols.

    Dr Dr David Perlmutter: Dark chocolate, though. The number you look for is you want to go north of 80%.

    Steven Bartlett: 80%. Because the higher that is, the lower generally is going to be the sugar content.

    I had the opportunity to make some chocolate in Peru, and I'll never forget the day. They gave me this massive tub and said, "We're going to make white chocolate first." There was a big bowl of sugar, and he said, "Pour in 70% of the white sugar into the bowl." And I was like, "What?" And I filled it up to there with sugar. And then there was this liquid we poured in. And I was like, "Wow, the white chocolate I eat is 70% sugar." And then milk chocolate was about 50%, and then obviously dark chocolate is —

    Dr Dr David Perlmutter: Right. And you know, you could go overboard on any of this and certainly go overboard on the chocolate. But the traditional diet that humans and proto-humans consumed was one that was rich in fibre — which these foods are — rich in polyphenols as demonstrated by the different colours you see here, and had very good levels of fat. The low-fat, low-fat-that that we were so programmed to gravitate towards — it gets to the broader theme of really the central issue here in terms of what's making us sick. This is a mismatch between what our genetics expect and what our genetics are seeing. Our genome that we are gifted from all generations who've come before us has been refined generation after generation. Right now, we are experiencing this incredible mismatch between our evolution — meaning our genes — and our environment. We are living a life that just doesn't send the appropriate signals to our genome. I've been interested in this since I was 15.

    Diabetes, Body Fat, and Inflammation

    Steven Bartlett: I've heard you say that people with type 2 diabetes have a 300 to 400% higher risk of Alzheimer's.

    Dr Dr David Perlmutter: Some studies have shown that. I think a number that we can absolutely support by more recent data is at least 75 to 85% increased risk. But what people may not be aware of is that even Parkinson's disease is increased in the type 2 diabetic by about 85%. Why would that be? Because when you look at the Parkinson's brain — and this data became evident in the late 1980s — you see activation of the microglia cells destroying that part of the brain called the substantia nigra, the black substance that makes dopamine. It's an activation of the microglia cells.

    The original work was fascinating. It was seen at Stanford University when suddenly people started showing up in the emergency room who developed Parkinson's in one day from shooting an IV designer drug that was contaminated with something called MPTP — a mitochondrial toxin that basically fried those cells in their brains that made dopamine. It became a powerful research tool. I was at a conference last week where MPTP was used in laboratory mice to create damage to that part of the brain and create Parkinson's. And now they've developed an offset for that — they're giving the mice MPTP but also giving them something called RNS60 that was able to keep these mice from having that damage occur by activation of their microglia cells.

    Steven Bartlett: So what is this? I think it's body fat.

    Dr Dr David Perlmutter: That's a pound of fat. And you don't want it here — you don't want it on your belly. You don't want it around your organs. That's called visceral fat. When you're 30 pounds overweight over ideal body weight, that's 30 of these. Think about that. And that's incredibly common.

    This is an organ. It looks like just stuff. We used to consider fat as being pretty inert — a resource for calories that we could tap into if we were starving. That's what it's intended for. But it is creating chemicals that have function throughout the body, and by and large these are chemicals that are damaging — pro-inflammatory chemicals called cytokines.

    Steven Bartlett: We think of fat as just being the byproduct of its storage for the food we ate. We don't think of it as an organ or that it's secreting or doing anything. But you're telling me there are chemicals coming off this?

    Dr Dr David Perlmutter: You bet there are. Pro-inflammatory chemicals are secreted by body fat. And they're not necessarily always bad — even the notion of inflammation always being bad, we challenge. We need inflammation. If we suddenly were able to reduce all the inflammation in your body immediately, you would perish. You need to have the inflammatory response. It's a life-saving activity. It's the excessive inflammation that gets us into trouble, or lower levels of inflammation over a longer period of time.

    People talked about the cytokine storm in COVID — this sudden explosion of cytokines, inflammation throughout the body damaging everything. I think we should consider things like Alzheimer's as not a cytokine storm, but as a cytokine drizzle — this is still an uptick of inflammation, though slight, but it happens over a long period of time.

    Steven Bartlett: We've got alcohol there as well on the table. What is your point of view on alcohol?

    Dr Dr David Perlmutter: There was a lot of data that showed what we call a U-shaped curve in terms of dementia risk. At the very lowest level — i.e. no consumption of alcohol — there was a certain risk for dementia. With consumption, the risk went down a bit — one glass of wine per day for women, two glasses of wine per day for men — but then the U comes back up. So we thought there was a sweet spot. It turns out that reassessing that data indicates that really any alcohol consumption is probably not good for the brain. The argument was, well, red wine has polyphenols — have a glass of red wine. We know that many people in the Blue Zones will drink some wine, as do I from time to time. But alcohol itself is a neurotoxin, and I think we'll get our polyphenols from coffee and extra-virgin olive oil.

    Steven Bartlett: How does alcohol harm the brain?

    Dr Dr David Perlmutter: It is directly toxic to neurons, and through the lens through which I see brain science these days, it helps polarise our microglia cells away from being supportive. It turns the good twin into the bad twin. Alcohol, high blood sugar, inflammation, stress, sedentarity, lack of restorative sleep, social isolation — all the things. And then when we have the M1 evil twin, how does this then directly increase our probability of getting dementia?

    Those microglia cells create havoc in the brain. They destabilise our neurons. They destabilise the blood-brain barrier — so now we're letting things in that can make the problem even worse. Most fundamentally, they destroy synapses. Neuroscience is now looking at Alzheimer's as what is a new term — a synaptopathy — a disease of the synapses, a loss of the synapses.

    And interestingly, I'll connect this segue for you. Why do women have twice the risk of Alzheimer's in comparison to men? Is it because they live longer? Not really. What has recently been identified is that the sudden drop of estrogen — particularly one estrogen called estradiol — at menopause causes the synapses to be labelled with signalling molecules called complement. That is basically what is called an "eat me" signal. There's a Dr. Beth Stevens at Harvard who's done some amazing work. The synapse binds a chemical called complement, and complement triggers these microglia — it says for you, M1 microglia, come and destroy this synapse. She's demonstrated this. You can actually see it happening. It's pretty breathtaking.

    Steven Bartlett: So the evil twin receives a signal to come and destroy parts of the brain. Why would the brain be doing that?

    Dr Dr David Perlmutter: Good question. These cells are activated for the reasons we've talked about — these metabolic changes, the inflammation, the exposure to polluted air, breathing these PM2.5 particles from wildfire — all of the things that are known to activate this microglia and cause it to do that. But I think more importantly, this explains why when we age, we're at higher risk. It's really, I think, the most exciting and fundamental area of neuroscience research right now.

    40 Hz Light Stimulation and Cutting-Edge Research

    Dr Dr David Perlmutter: So how does it work? What's the research doing now? There's a Dr. Li-Huei Tsai at MIT, and what has she done? She's demonstrated that the non-Alzheimer's brain has a beautiful background rhythm called gamma oscillation — a beautiful sinusoidal rhythm underlying the brain. The Alzheimer's brain has a disrupted rhythm. It doesn't have that beautiful sinusoidal rhythm.

    She stumbled upon the idea that brain rhythms change based upon frequencies of light that are put in front of a laboratory animal. She found in the laboratory rodent that is geared to get Alzheimer's — one of the experimental tools that we use — that a light flashing at 40 times per second, 40 hertz, restores the background gamma. And she said, "Well, that's interesting. I wonder what effect that's going to have in humans." What she found was that 40 Hz light and 40 Hz sound — she has a device that does this — restores this gamma oscillation in the brain and reverts microglia cells back to being supportive.

    Steven Bartlett: The evil twin cells back to being supportive. So she's actually done this technique in humans with Alzheimer's. What does that mean for the average person?

    Dr Dr David Perlmutter: I have a 40 Hz light generator on my desk. According to the science, it is keeping my microglia doing what they need to do. She's actually done interventional trials in patients with existing Alzheimer's disease, and her results are better than any drug that targets beta-amyloid. The beta-amyloid drugs are the FDA-approved treatment, and I make it very clear in my recent book that these drugs are for the most part ineffective and significantly dangerous. My vote is that they are not to be used.

    40 Hz sensory stimulation — most famously pioneered through strobe lighting, flickering LEDs, or auditory clicks — has emerged as one of the most intriguing non-invasive approaches to recruiting microglia to clean up the brain. In animal models, just one hour of daily 40 Hz light stimulation drove significant drops in plaque and tangle burden.

    I keep a device right by my computer screen and it's passively shining that light into my eyes. Can I prove that it's doing anything wonderful for me? No. But am I a believer in the science? You bet I am.

    Steven Bartlett: Just closing off on the subject of alcohol — you said in your book on page 102 about a study where they found that microglia exposed to binge-level alcohol for 24 hours showed a 15% decrease in their ability to clean out beta-amyloid.

    Dr Dr David Perlmutter: Exactly. So someone binge drinks for 24 hours and the microglia drop in their ability by 15% as it relates to their ability to clean out that beta-amyloid — which is the plaque associated with Alzheimer's.

    Steven Bartlett: Yeah, it's the plaque associated. It's not the pivotal player, but it's important.

    Dr Dr David Perlmutter: I can't afford a 15% reduction. They're already downregulated towards M1 because of my age. That's the vote against alcohol. And even one night of non-restorative sleep does the same thing — even more so. One night of not getting a good night's sleep dramatically reduces your ability to clear beta-amyloid.

    Steven Bartlett: Can you recover from that? Because there's going to be a lot of people thinking, "I had seven bad nights last week."

    Dr Dr David Perlmutter: I know you travel a lot between LA, New York, and London. In neurology school, they teach you, well, what do you do for the Alzheimer's patient once the problem has begun? And great — I'm glad people are looking at that and doing research. But sowing the seeds at your age is when it really begins.

    Sugar Rationing, the Gut Microbiome, and Early Life

    Dr Dr David Perlmutter: Let me take this. There's one interesting study that was just published and it just blows my mind. It was done looking at women who conceived in the year 1953 — right where you and I are sitting right now, here in England — and whether they had sugar rationing or they didn't. The sugar rationing from World War II was still in place in 1953. It looked at a large cohort of women and followed them for a number of years — at least 50, 60, 70 years — and what it found was that the women who had sugar rationing, who weren't able to get sugar while they were pregnant and for one thousand days — so through pregnancy and then the first couple of years of life — the risk of that child, now 60, 70, 80 years old, developing Alzheimer's was reduced by 40% because mother didn't have access to sugar when she was pregnant.

    People are always saying, "Dr. Perlmutter, when should the Alzheimer's prevention program begin?" My standard response is, "Well, we've got to be paying attention in our 30s and 40s." But this really winds the clock back, doesn't it?

    Steven Bartlett: What is the mechanism though?

    Dr Dr David Perlmutter: I think there are multiple mechanisms. Sugar in and of itself — raising blood sugar — compromises brain function and even the genesis of the brain. But I think sugar also changes the makeup of the gut bacteria. Higher levels of dietary sugar change the array, the function, the diversity of the bacteria and other organisms that live within the gut, like yeasts for example.

    Steven Bartlett: And the baby has the mom's gut microbiome?

    Dr Dr David Perlmutter: Actually, the baby does not really have much of a microbiome until such time as it's born. The method of birth is really fundamentally important for the development of that newborn's microbiome. In other words, caesarean section versus a vaginal delivery has a huge impact. When a baby passes through the birth canal, it's being anointed with a special concoction — a special array of organisms in the birth canal.

    Steven Bartlett: Bacteria —

    Dr Dr David Perlmutter: Bacteria and viruses and yeast — all kinds of organisms that get in the baby's eyes and its nose and its mouth. I call it an anointment. It's a blessing — that this newborn gets his or her microbiome started, seeded at that moment based on how it's birthed. Being born by caesarean section, that newborn will develop a microbiome based upon what was on the surgeon's glove at the time that baby was delivered.

    In fact, there is research being done — I think at NYU — where if women are going to have a C-section, they take a swab of the vagina. The baby is born by C-section. Then that swab, which still contains those secretions, is placed in the baby's nose and its mouth to help restore that specific type of microbiome.

    Steven Bartlett: What is the link between the microbiome and Alzheimer's and dementia?

    Dr Dr David Perlmutter: I think the link is quite profound. These organisms are making things that are good for the brain — very specific types of short-chain fatty acids, for example, that are important for brain functionality. The microbiome organisms are secreting chemicals that are changing gene expression throughout our bodies and of course in the brain.

    I think the biggest issue is when we have changes in these microbes — which can be brought on, for example, by taking certain medications. We happen to have them here — proton pump inhibiting drugs. These are acid-blocking drugs that people take because they think they need to lower their stomach acid based upon what they're seeing on television or elsewhere. When you change the pH of the gut, you're changing the organisms that live there and their function. And when you do that, it can lead to increased leakiness or permeability of the gut lining. That sets the stage for inflammation in the body. Those inflammatory chemicals can then make their way throughout the body and into the brain. What do they do there? They polarise our supportive, loving M2 microglia to being destructive.

    Steven Bartlett: So the TSPO images that show — what's that?

    Dr Dr David Perlmutter: The TSPO is simply a way in living humans to demonstrate activation of their microglia cells — these immune cells, these evil twin things. Let me be a little kinder to our M1 microglia. There's a time and a place — when we have an acute injury or acute infection, we want to have that type of microglia cell to do its job, to destroy or neutralise. When we have a head injury, for example, we activate our M1 microglia. But we have to be able to revert back to being the supportive microglia cell — the healthy one. When we keep our microglia in their destructive phenotype or configuration after the event has occurred, it leads to delays in improvement or even lack of improvement.

    Steven Bartlett: Improvement in what?

    Dr Dr David Perlmutter: Good question. We know that football players, for example, get this encephalopathy — when they bang their heads playing football too many times, they experience this progressive neurodegenerative condition that ultimately may kill them. But they're not banging their heads anymore. Why? Because the microglia cells that appropriately responded don't revert back.

    Steven Bartlett: Oh, so it's kind of like boxers who finish boxing, but then gradually you watch them deteriorate. You watch their speech slur, their memories —

    Dr Dr David Perlmutter: We're both right now thinking about Muhammad Ali. How tragic was that? That's called pugilistic Parkinsonism — pugilist means a boxer. But any bump to the head — whether it's playing soccer, there was a study that came out last week that looked at F1 drivers as being at risk. The first F1 driver I think that developed CTE — chronic traumatic encephalopathy — made the news just a week ago. You've got to protect your head. You really have to protect it against trauma.

    There's an interesting study that shows that if you have head trauma, your risk of poor outcome is increased if you happen to have been a type 2 diabetic prior to the head trauma. Outcome of head trauma in type 2 diabetics is much worse. Why? Because that type 2 diabetes is shifting their microglia, preventing them from coming back and being helpful, being supportive — shifting it to the evil twin.

    Mitochondria, Metformin, and the Future of Treatment

    Steven Bartlett: Okay. So one of the big takeaways from this conversation is the decisions I make in my everyday life — what I put in my mouth, the exercise I do or don't do, the alcohol I do or don't drink — is all going to impact this ultimately.

    Dr Dr David Perlmutter: That's the event. And upstream of that are the changes in the mitochondria, the energetics of what is going on here. That is playing a really important role, such that we are now looking at what can we do to enhance mitochondrial function. Because when mitochondrial function is restored, it helps keep our microglia in their supportive role.

    There are transplant techniques now for transplanting healthy mitochondria into human hearts and very soon into human brains. There are ways that we increase our mitochondria in terms of their numbers, their function, and our ability to get rid of defective mitochondria. Exercise does it, and metformin does it as well — this drug that is being used right here in England now as part of a treatment protocol for Alzheimer's.

    Steven Bartlett: Metformin — it's a diabetes drug. It's not targeting beta-amyloid. But the average person shouldn't be taking that, should they?

    Dr Dr David Perlmutter: That's a great question. I was at a conference dealing with health span and aging — a very small conference, about 20 people. The question was asked, "How many of you are taking metformin?" This was about eight years ago, and I think 80% of the scientists raised their hands. What you're not hearing from me right now is that we should all jump on board and take metformin. I prefer to exercise. But there is a big study called the TAME trial. Neil Barzilai at Albert Einstein is trying to get this started but looking for funding — it's about a $70 million project. He can't get funding because metformin has gone off patent, so nobody's going to get the brass ring at the end of the day. But it's looking at the intervention of taking metformin to see what effect it has on longevity and dementia for generally healthy non-diabetic people.

    Steven Bartlett: The current scientific consensus is not to take metformin for routine use in healthy adults because there are some potential consequences. Number one, it blunts the benefits of exercise. Multiple randomised control trials have demonstrated that metformin actively interferes with exercise adaptations. Number two, there's a risk of masking lifestyle fundamentals — intensive lifestyle modification consistently outperforms metformin in reducing cardiovascular risk. Relying on a pill to simulate metabolic health cannot replicate the systemic vascular and psychological benefits of movement, sleep, and whole foods.

    Dr Dr David Perlmutter: And I don't think mentioned in this article was the possibility of B12 deficiency that we see in people taking metformin. Dr. David Sinclair — you've had him on the podcast — he recently put out a paper several months ago that looked at all these cool interventions as it relates to aging clocks, and it ranked them. Metformin was described, rapamycin was described. What led the list — and he's a big NAD guy, as you know — what led the list was exercise in terms of these aging clocks. So again, it gets back to this: what did our ancestors do? They were active. They didn't suffer from this sedentarity — this idea that we're just sitting on our butts all day, flying here and there, in front of computers.

    To me, this has been the central focus of my understanding as to why we are sick. I wrote a paper about this when I was 15.

    Steven Bartlett: 15?

    Dr Dr David Perlmutter: I wrote a paper about it and it was published in the Miami News. I simply concluded that the world in which we live, we are not able to adapt quickly enough, genetically enough, to be able to survive in the world that has suddenly turned the tables on us.

    Steven Bartlett: So what is this? This is when you were 15 years old.

    Dr Dr David Perlmutter: It is.

    Steven Bartlett: "Perhaps the human will change rapidly in the next centuries to adapt himself to beer cans, concrete, and shattering noise. Our generations are each contributing to the evolution of pollution-resistant lungs. But what about the people of today who are stuck with the outdated machinery?"

    And that was written by this young man. You're about 17 years old there, but nearly.

    Dr Dr David Perlmutter: No. By 17 I had grown long hair. I was a pudgy little one, wasn't I? That was my bar mitzvah tie, too, as a matter of fact.

    Family, Legacy, and Personal Motivation

    Steven Bartlett: Got a picture here of your son as well — Austin.

    Dr Dr David Perlmutter: You look very similar.

    Steven Bartlett: More similar now than —

    Dr Dr David Perlmutter: Well, I'm going to take that as a very big compliment. And more than that, he's taught me a lot. In many ways he's a mentor, and it's so wonderful watching him become a father. It's changed him in ways he cannot yet begin to appreciate. I think not yet, but he will. And our daughter — watching her blossom as an artist on the world stage — it's just breathtaking to watch the two of them. When you have your children, that's going to be a real game-changer for you.

    Steven Bartlett: Did it change a lot of how you think about the brain and the body and longevity and all the subjects we've talked about today? Preserving oneself now that you've got a grandson and a granddaughter?

    Dr Dr David Perlmutter: I've absolutely doubled down on everything that I do to be a grandfather. I became a grandfather kind of late in life — here I am at 71. Most of my friends who have grandchildren, their grandchildren are already in their late teens. So I've got to do the best I can. I don't want to be "do as I say, not as I do." I want to be as transparent as possible with my foibles and with the things that I think are important.

    Fundamentally, what we're talking about today changes the ownership and the responsibility. And perhaps there's a criticism there, but my goal is to give agency. We offload our agency to the hope of the development of cures. James Cameron, the movie director, famously said that hope is not a strategy. I want to provide a strategy to improve your odds of not experiencing this cognitive decline — which is not just a devastating issue for you, but by that time for your wife, your children. It's an awful situation and the cost is profound.

    So when I say that the drugs are ineffective, in the context of hope that there will be effective drugs — I just saw a powerful study come out of Havana, Cuba of all places, giving an intranasal treatment of something called erythropoietin, which is something made by the kidneys, that had effects in existing Alzheimer's patients that were mind-blowing. Patients who would have declined — who did decline in the placebo group by four points on a standard scale that we use — improved four points. So they didn't just stabilise; they got better.

    Advice for Those Already Living with Dementia

    Steven Bartlett: For those people that do have Alzheimer's or have a relative that has Alzheimer's now — I imagine there's a lot of them listening. A lot of the reasons why they click on these videos is because they've just received a diagnosis or they're living with it and they're in search of answers. What is there that we can offer to people who unfortunately are now dealing with dementia in their family or within their own brain?

    Dr Dr David Perlmutter: What do we offer? And why should you believe me? I'm swimming upstream here. I am indicating that what the FDA has approved in America is not the way to go. I'm indicating that when we look at a relatively small study from Harvard University — obviously well respected — by Tanzi and Dean Ornish, where they took a group of 51 individuals who have Alzheimer's disease or mild cognitive impairment and changed their lifestyle. They increased their exercise. They changed their diets. They reduced their stress and they had to meditate for an hour a day. These people didn't just slow their decline in the relatively short intervention of 20 weeks — 70% of them either stabilised or improved.

    Steven Bartlett: What did they do to their diet?

    Dr Dr David Perlmutter: They put them on a plant-forward, more Mediterranean-type diet. A diet rich in the things that we just looked at — rich in polyphenols, rich in colour. Welcome back to the table fat, but the good fats. And encouraging social interaction. People improved.

    So that's what I say to anyone who's listening: pay close attention to your blood sugar. Get your weight down. And most importantly, this powerful tool — a pair of running shoes. That is the salvation, in my opinion.

    Steven Bartlett: What did the Cochrane analysis that was just published say about these Alzheimer's drugs?

    Dr Dr David Perlmutter: I wrote in my last book the idea that I am not in favour of the use of these amyloid-targeting drugs. I said it because they are for the most part ineffective and they have a significant risk profile. This Cochrane analysis looked at 20,342 individuals in 17 different studies, 18 months each study, and asked two simple questions: do the drugs work in the Alzheimer's patient that target beta-amyloid, and are they safe? They found that the drugs basically have no meaningful effect in slowing the progression, much less leading to improvement.

    The Ketogenic Diet and Brain Energy

    Steven Bartlett: What about the ketogenic diet as a way to deal with the symptoms of dementia?

    Dr Dr David Perlmutter: I think more than the symptoms — when you're talking about the ketogenic diet, you're targeting the mitochondria. Ketogenic diet along with exercise — we're targeting mitochondrial function. And remember, that is the pivot point for determining supportive versus destructive microglia.

    Steven Bartlett: And by keto diet, for anyone that doesn't know, we basically mean a very low carb diet — less than maybe 50 grams of carbs per day — with the addition of more fat to the diet, good fat, the extra-virgin olive oil with nuts and seeds.

    In clinical trials on mild cognitive impairment and early Alzheimer's, a keto diet or ketone supplementation rescues roughly 10 to 18% of the brain's total energy supply, directly closing up to 80% of the fuel gap left by impaired glucose metabolism. This energetic boost translates to up to 15% improvement in standard memory and test scores, alongside up to a 20% gain in daily functioning, helping patients manage basic self-care and everyday tasks with greater independence.

    Dr Dr David Perlmutter: When you target mitochondria, it's a good thing for the brain. The brain requires glucose, and when we become insulin resistant, certain parts of the brain suffer. Not all of the brain cells require insulin, but some parts do — the hippocampus, the memory centre; the hypothalamus, which controls our metabolism; the prefrontal cortex, which allows us to make good decisions and helps direct our behaviour; and finally an area called the olfactory bulb, which is involved in smell. When you think about it, everything I just mentioned are issues in Alzheimer's. We become forgetful, our metabolism goes haywire, we lose executive function, and we lose our sense of smell. So this is an upstream energy deficiency — the inability of the brain to use energy. You can bypass that with the ketogenic diet, and also in Parkinson's. There is a researcher in New Zealand named Matthew Phillips who has published papers on each of those, and I wrote a book chapter with him on the use of the ketogenic diet in Parkinson's.

    Steven Bartlett: It's hard to adhere to the ketogenic diet though, isn't it?

    Dr Dr David Perlmutter: I'm not saying one needs to do that at all times. I think what you want to try to establish is flexibility, such that when you do decide you're going to fast for a day or two, or stick to the very low carb and higher fat regimen, you're able to jump into ketosis relatively quickly — as opposed to having to adapt to a ketogenic state, which may take a couple of weeks.

    Supplements, Personalised Medicine, and Closing Thoughts

    Steven Bartlett: Dr. David, what is the most important thing we haven't talked about that we should have talked about — as it relates to Alzheimer's, dementia, and generally just having a healthy brain for those that maybe aren't thinking so much about a disorder, but just want to be able to show up in their lives on a daily basis and be their best?

    Dr Dr David Perlmutter: Everything that we have talked about today in terms of brain degeneration is equally valuable in terms of brain performance. So if you want your brain to perform at its optimal level, these are the exact same keys to the kingdom.

    Steven Bartlett: Are you a fan of supplements?

    Dr Dr David Perlmutter: I absolutely am. I have a bit of a genetic quirk that goes by the name of MTHFR. What that means is I don't handle B vitamins as well as I should. As such, my homocysteine level was elevated. Homocysteine itself is an amino acid that is a significant risk factor for heart disease and Alzheimer's. So because of my unique genetics, I have to take a different type of B vitamin called methylated B vitamin. That's first and foremost for me — and for probably about 25% of the global population.

    Steven Bartlett: What else do you take?

    Dr Dr David Perlmutter: I take DHA from fish oil — omega-3. But we want to look at the DHA content. My fish oil contains about 1,000 milligrams a day of DHA.

    Steven Bartlett: When we talk about people that are living with someone with Alzheimer's, we often hear from the family what it was like to essentially lose the person they loved. What is it like for the person that has Alzheimer's?

    Dr Dr David Perlmutter: It's a great question. I think early on it's incredibly distressing. When you ask people what disease they fear most, overwhelmingly the answer is Alzheimer's. It's not cancer. It's not heart disease. It's losing the ability to make your own decisions and to self-care.

    Steven Bartlett: Do they know that they're losing it?

    Dr Dr David Perlmutter: Early on, yes. And it gets to a point where they don't realise, and that's a blessing. I watched that happen to my dad. He was ultimately unaware. When you lose these subtle cognitive functions early on, you know damn well something's going on.

    Steven Bartlett: How long did that take in his case?

    Dr Dr David Perlmutter: Between when his behaviour changed to his passing took about five years.

    Steven Bartlett: Five years. And is it the disease that ends up killing the person, or is it something else?

    Dr Dr David Perlmutter: It's the disease. Everything ultimately just shuts down. He did not, I believe, carry APOE4 — I don't know what his genetic profile looked like. I don't know my mother, so I can't figure out whether my dad did carry the APOE4. And to be sure, there are 80 other genetic issues that relate to Alzheimer's risk. But again, genetics loads the gun. Lifestyle pulls the trigger.

    Steven Bartlett: What were those five years like in terms of how he changed?

    Dr Dr David Perlmutter: Well, you have to start at his baseline. He was a towering human — just in terms of his contribution and his compassion. And to be fair to others more so than to family — I'll call it out like it was — which is something I've worked through, and I think helps explain why I've been as driven as I have been throughout my life, to get recognition that perhaps I could have gotten earlier in life.

    When he was aware of it, he was one to deny and offload blame. "I never said that," or "You must have misplaced this." He became a bit accusatory of things that were happening. When he couldn't find things, he would accuse people of moving things around. And then as it progressed, his issues became less and less of an issue for him and more and more of an issue for all the rest of us.

    Steven Bartlett: Was there a moment where he realised his brain was changing?

    Dr Dr David Perlmutter: Yes. And by circumstance, the nursing home in which he lived — his apartment in the nursing home — was across the parking lot from my clinical neurology Alzheimer's practice, such that I could see his room from my examining room. I'd be meeting in the examining room with families of patients, and I could see his room while the conversations were going on. They'd say, "Doc, you have no idea what we're going through with mom or dad." And I would stop and I would say, "Let me hold you right there, just so we can relate as humans. That room that you see across the parking lot — that's where my father lives now and he's dying from this disease. So I get it. Now you know who your team player is."

    And gradually the decline meant that he didn't know who he was. Beyond that, he was totally unable to function. That's the endgame in Alzheimer's. It's a total lack of ability to engage in any meaningful interaction with others or any meaningful activity. You're just in bed with a blank stare on your face. And when you see your parent like that and think back to who he was and what he was, it's difficult. And I don't want people to go through that. I really don't.

    And if I'm a pain in the ass by saying the things that I say — don't put your faith in the drugs, make these changes today because they're hard, and I wish medicine would do these things — I'm not going to apologise. Because that's what answers your very first question. What am I doing? I'm doing my best so people don't have to experience what I'm feeling right now. And I'm a 71-year-old man and I'm not over it. And I realise I'm not ever going to be over it. And that's not a bad thing, because it motivates me. It gives me the courage to go before your audience — I know that it is vast — and to make these statements. Because if one person gets this message, then I've done my job.

    And my hope is that a lot of people get this message — that we need to regain agency and not be persuaded to hope that there's a wonder drug out there. That's just inappropriate. It's wrong and it's absolutely cruel, and I object to it.

    Austin's Letter

    Steven Bartlett: Well, you're a dad yourself now and you have this wonderful son called Austin. I actually spoke to Austin, and Austin wrote a little letter for you. Here you go. This is from your son Austin. You can read it.

    Dr Dr David Perlmutter: "For the entirety of my life, you've been an example of passion personified. Whether it was for your patients, your family, or the millions of people you reach on podcasts like this one, you've always cared so much about helping others and empowering us with tools to make our lives better. I'm so proud to watch as you help people understand and improve their brain health. It matters. I see it in the messages I get from people telling me just how much you did for them and their families. I hear it at conferences when people tell me about the things you did for them decades ago. I'm honoured to have you as my father. And most lately, I'm filled with the joy to see you become an exceptional grandfather. You are an incredible continuation of the work of your father. I can't wait to see you soon. Love from all of us across the pond. Austin."

    Well, Steven, you really did it here, didn't you? I'm thinking of my dad right now. We go through our lives trying to do the right thing, and he set a very high bar. He really did. The Dalai Lama said that if you want others to be happy, be compassionate. And if you want to be happy, be compassionate. In many ways, these are tears of joy. I am so happy with how it's playing out because I'm in my lane. It feels really good to be in my lane and to have identified what my skill set is and exploiting it to the ends of the earth. That's what it's all about.

    Probably a better answer to your opening question. I think that's enlightenment — identifying your skill set and using it to contribute. And I will continue as long as my brain holds up, and I'm doing all the right things, so hoping that it does.

    As Austin said, you are a wonderful continuation of your father's work. At his eulogy, I sang — I think it's a Dan Fogelberg song — just a line: "My life has been a poor attempt to imitate the man. I'm just a living legacy to the leader of the band." And why not continue on the legacy and teach by example? Doctor means teacher. It doesn't mean healer. So that's what we do. That's what you do. All the things that go on on this podcast — it's all about teaching. Whether it's about should we take creatine or should we not take creatine, or what is the cause of aging. It's teaching, and it marries curiosity with compassion. And that's a great marriage, because curiosity gives you the tools to really be compassionate, and at least in medicine it sure does.

    Closing Words

    Steven Bartlett: Everything we've talked about today comes back to this old fella — the brain. What are your closing words for people about their brain? What can we say to them to make sure that they walk away from this conversation and do everything they can to protect it?

    Dr Dr David Perlmutter: In a word: reconnect. If we reconnect with others and reconnect with relationships, it will go a long way to improving our lives, improving our brain health, and improving the planet. Austin and I wrote a book called Brainwash. We define in this book something called disconnection syndrome — at a microscopic level, how the brain gets disconnected from its prefrontal cortex, which we talked about — and on a macroscopic level, how disconnected we're becoming from each other. There's personal benefit — we talked about that through oxytocin. But we've got to reconnect with each other. We've got to reconnect with the planet. We're all in this together. That would be, I think, my most important message.

    Steven Bartlett: Well, you certainly are one for a message. You've written so many incredible books. Your most recent book, Brain Defenders: Harness the Power of Your Immune Cells to Protect Your Brain for Life, came out — I think the day after my birthday, August 27th. I'll link it below. I know there are lots of my audience that are especially keen to avoid dementia and Alzheimer's because it runs in their family, and they've seen the horrific consequences of the disease. And this is a wonderful book to take back a bit of agency — as you describe — and feel like there is some control over something that feels so helpless.

    Dr Dr David Perlmutter: You bet. And you're a good man. You're a sweetheart. I'm sure grateful to meet you and spend time with you today. The consequence of your father is you — and the millions and millions of people that you've reached and helped, given them some information, turned the lights on in their life, which gives them that agency that we describe. And I think agency is most valued at times when we feel hopeless. That's certainly what you've done for so many — given them both actions that they can take, but a sense of hope. And that's truly a wonderful thing. So thank you for doing that work, Dr. David.

    Dr Dr David Perlmutter: Thank you, Steven.

    Steven Bartlett: We do have a closing tradition where the last guest leaves a question for the next — not knowing who they're leaving it for. The question left for you is from Mark Hubin. And the question is: what makes you emotional?

    Dr Dr David Perlmutter: It's an excellent question, but I think we've answered it.


    Polished transcript of The Diary Of A CEO. All views are those of the original speakers. Watch on YouTube ↗
    Published by @healthynut
    More from The Diary Of A CEO
    More from @healthynut
    Summary